Private Equity

With major institutional backing, a fast-growing lender is financing a new generation of upscale, affordable manufactured homes to tackle the housing crisis.

Acertis Pharmaceuticals secures rights to Licart, a unique once-daily NSAID patch, aiming to disrupt the competitive U.S. topical pain relief market.

BizClik’s Net Zero Summit will feature an SGS workshop to help leaders turn complex ESG regulations into a strategic advantage amid global compliance shifts.

Certuity poaches veteran talent from UBS, JPMorgan, and BNY Mellon to launch a major expansion in New York, Atlanta, and Denver. What does this mean for UHNW wealth management?

Atmus Filtration Technologies acquires Koch Filter for $450M in a major market expansion, while ADTi names a new CEO to lead a sharpened strategic focus.

Amid soaring demand for skilled labor in Georgia, a new trade school in Decatur offers a fast track to careers in welding, HVAC, and electrical trades.

A biotech firm's promising concussion therapy, backed by NFL's Alex Smith, shows an 85% responder rate and now seeks public funding for its final push.

The deal merges digital orchestration with field AI, promising pharma a unified, rapid-deployment engagement solution to challenge industry giants.

The global asset manager appoints Kikuo Shirose to lead its Japan office, signaling a deep push into the nation's booming real assets and alternatives market.

The deal creates an end-to-end commercialization powerhouse, tackling pharma's toughest payer, reimbursement, and patient affordability challenges.

Blackstone is now the sole institutional backer of AIR Control Concepts, fueling the HVAC leader's rapid growth and strategic expansion into the booming data center market.

A new joint venture provides crucial short-term loans, aiming to unlock permanent financing for affordable housing projects facing a critical funding gap.

Net lease REIT W. P. Carey reports a landmark 2025, funding record deals by strategically exiting self-storage and fortifying its industrial portfolio.

Vera Therapeutics' novel IgAN drug gets FDA fast-track review, promising a new at-home treatment for a debilitating autoimmune kidney disease.

Private equity firm Insignia Capital invests in Trooh Media, signaling a major bet on digital billboards as the key to reaching young consumers.

With a device that calms deadly 'cytokine storms,' SeaStar Medical targets vast new markets, but can the small company deliver on its huge promises?

Azitra will present its novel AI-driven skin therapies for rare diseases at Biotech Showcase, seeking crucial funding and partnerships to advance its pipeline.

As Sotera Health prepares for the J.P. Morgan conference, strong financials clash with legal challenges, putting its mission-critical role under scrutiny.

A landmark public-private deal secures Groupe Somavrac's future, safeguarding 500+ jobs and a critical link in Canada's St. Lawrence Seaway supply chain.

Lotus Infrastructure acquires a major Long Island power plant, a move that highlights the complex balance between grid reliability and clean energy mandates.